Expression and role of COMT in a rat subarachnoid hemorrhage model

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 181-187

  He, Zhaohui ^a   Sun, Xiaochuan ^a   Guo, Zongduo ^a   Zhang, John H ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Cerebral vasospasm; COMT; Subarachnoid hemorrhage

Indexed keywords

CATECHOL METHYLTRANSFERASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; BASILAR ARTERY; BRAIN TISSUE; BRAIN VASOSPASM; CHIASMATIC CISTERN; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MORPHOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

EID: 85052609235     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0353-1_32     Document Type: Conference Paper

References (27)

1. Ansar S, Svendgaard NA, Edvinsson L. Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction. J Neurosurg. 2007;106(5):881-6.
2. Oruckaptan HH, Caner HH, Kilinc K, Ozgen T. No apparent role for neutrophils and neutrophil-derived myeloperoxidase in experimental subarachnoid haemorrhage and vasospasm: A preliminary study. Acta Neurochir (Wien). 2000;142(1):83-90.
3. Ferro JM, Canháo P, Peralta R. Update on subarachnoid haemorrhage. J Neurol. 2008;255(4):465-79.
4. Brisman JL, Eskridge JM, Newell DW. Neurointerventional treatment of vasospasm. Neurol Res. 2006;28(7):769-76.
5. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998;9:615-27.
6. Shen Jian-Kang JK. The pathogenesis of cerebral vasospasm and its prevention and treatment. Int Cerebrovas Dis. 2006;14(7):481-93.
7. Otten ML, Mocco J, Connolly ES Jr, Solomon RA. A review of medical treatments of cerebral vasospasm. Neurol Res. 2008;30 (5):444.
8. Cahill J, Zhang JH. Subarachnoid hemorrhage: Is it time for a new direction? Stroke 2009;40(3 Suppl):S86-87.
9. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994;25(7):1342.
10. Solomon RA, McCormack BM, Lovitz RN, Swift DM, Hegemann MT. Elevation of brain norepinephrine concentration after experimental subarachnoid hemorrhage. Neurosurgery 1986;19(3):363-6.
11. McCormackBM, SwiftDM,HegemannMT, SolomonRA. Increased norepinephrine synthesis in the cerebral hemispheres of rats following subarachnoid hemorrhage. Brain Res. 1986;382(2):395-8.
12. Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen Jr. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery 1992;31(1):42-50.
13. Naredi S, Lambert G, Edén E, Záll S, Runnerstam M, Rydenhag B, Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000;31:901-6.
14. Magnoni MS, Kobayashi H, Frattola L, Spano PF, Trabucchi M. Effect of common carotid occlusion on beta advenergic receptor function in cerebral microvesels. Stroke 1985;16(3):505-10.
15. Chung YH, Shin CM, Kim MJ, Cha CI. Enhanced expression of Ltype Ca2+ channels in reactive astrocytes after ischemic injury in rats. Neurosci Lett. 2002;302(2):93-9.
16. Meguro T, Chen B, Lancon J, Zhang JH. Oxyhemoglobin induces caspase-mediated cell death in cerebral endothelial cells. J Neurochem. 2001;77(4):1128-35.
17. Meguro T, Chen B, Parent AD, Zhang JH. Caspase inhibitors attenuate oxyhemoglobin - induced apoptosis in endothelial cells. Stroke 2001;32(2): 561-6.
18. Delbarre B, Delbarre G, Rochat C, Calinon F. Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acid, and free radicals in gerbil brain after cerebral ischemia. Mol Chem Neuropathol. 1995;26(1):43-55.
19. Furukawa N, Arai N, Goshima Y,Miyamae T, Ohshima E, Suzuki F, et al. Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata. J Neurochem. 2001;76(3):815-23.
20. Miyazaki H, Ono T, Okuma Y, Nagashima K, Nomura Y. Glial cell line-derived neurotrophic factor modulates ischemia-induced tyrosine hydroxylase expression in rat hippocampus. Eur J Neurosci. 2000;12(6):2032-8.
21. Kobori N, Clifton GL, Dash PK. Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: Implications for prefrontal dysfunction. J Neurotrauma. 2006;23(7):1094-102.
22. Abe N, Tominaga S, Ohta H, Kawakami H, Tagawa K, Suzuki T, et al. Changes in plasma dopamine-beta-hydroxylase activity in patients with acute subarachnoid hemorrhage. No To Shinkei. 1979;31(8):771-7.
23. Kovacic S, Bunc G, Ravnik J. Correspondence between the time course of cerebral vasospasm and the level of cerebral dopaminebeta-hydroxylase in rabbits. Auton Neurosci. 2006;130(1-2): 28-31.
24. Mánnistö PT, Kaakkola S. Catechol-O-methyltransferase (COMT): Biochemistry molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999; 51(4):594-622.
25. Li S, Liu A, Ti X, Que H, Yang S, Zhang X, et al. Expression changes of metabolism-related enzymes in the lung tissues of rats with pulmonary embolism. Journal of Xi an Jiaotong University (Medical Sciences). 2006;27(6):529-32.
26. Redell JB, Dash PK. Traumatic brain injury stimulates hippocampal catechol-O-methyltransferase expression in microglia. Neurosci Lett. 2007;413(1):36-41.
27. Shirakawa T, Abe M, Oshima S, Mitome M, Oguchi H. Neuronal expression of catechol-O-methyltransferase mRNA in neonatal rat suprachiasmatic nucleus. Neuroreport 2004;15(87):1243-39.